Life Biosciences
Life Biosciences is a Boston-based biotech company developing gene therapies that aim to reverse aging in cells. Its lead therapy, ER-100, is in human trials for vision loss caused by glaucoma and other optic nerve diseases.
Analytics date: 05.11.2026
Basic information
Head office
75 Park Plaza, Level Three, Boston, MA 02116, USAHead officeGeography of business
United States of America- Singapore
Geography of businessDate of the last round
Last round 04/2026Date of the last roundTotal funds raised
$212M+Total funds raised
Analytics date: 05.11.2026
The ratio of valuation to investment among companies in the sector
The histogram shows the ratio of the companies’ value to the sum of investments received (= valuation / investment). The post-money valuation of the last round is used as the companies’ value. The volume of investments is the amount of funds raised by the company during all rounds + debt financing. The histogram shows the coefficient obtained by dividing the value of the company by the sum of investments received by it. Accordingly, the higher the coefficient, the better: the less money the company needed to achieve its valuation. The companies on the histogram are arranged in descending order of the coefficient.
